The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Ocular drug delivery systems: An overview
Open accessAbstract
gels, implants, contact lens and microneedles have been discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Parveen, S., Mitra, M., Krishnakumar, S., & Sahoo, S. K. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.02.010 · Cited by 63
RetractedRemington: The science and practice of pharmacy
(1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)90065-6 · Cited by 1,433
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Dendrimers: From Design to Application—A Progress Report
Fischer, M., & Vögtle, F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · Cited by 828
Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
Donnelly, R. F., Singh, T. R. R., & Woolfson, A. D. (2010) · Drug Delivery · doi:10.3109/10717541003667798 · Cited by 708
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346
Microemulsions as ocular drug delivery systems: recent developments and future challenges
Vandamme, T. F. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00017-9 · Cited by 345
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330
Ophthalmic Drug Delivery through Contact Lenses
Gulsen, D., & Chauhan, A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 304
Biodegradable Implants for Sustained Drug Release in the Eye
Lee, S. S., Hughes, P., Ross, A. D., & Robinson, M. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0159-x · Cited by 289
Coated Microneedles for Drug Delivery to the Eye
Jiang, J., Gill, H. S., Ghate, D., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286
Ocular release of timolol from molecularly imprinted soft contact lenses
Hiratani, H., Fujiwara, A., Tamiya, Y., Mizutani, Y., & Alvarez-Lorenzo, C. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.030 · Cited by 285
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle
Gulsen, D., & Chauhan, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.033 · Cited by 277
Ali, H. S. M., York, P., Ali, A. M. A., & Blagden, N. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.007 · Cited by 253
Intraocular implants for extended drug delivery: Therapeutic applications
Bourges, J. L., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Behar-Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235
Liposomes for intravitreal drug delivery: A state of the art
Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 227
Bhatta, R. S., Chandasana, H., Chhonker, Y. S., Rathi, C., Kumar, D., Mitra, K., & Shukla, P. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.060 · Cited by 224
Koo, H., Moon, H., Han, H., Na, J. H., Huh, M. S., Park, J. H., Woo, S. J., Park, K. H., Chan Kwon, I., Kim, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.030 · Cited by 214
Amrite, A. C., & Kompella, U. B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0005 · Cited by 212
Intrascleral Drug Delivery to the Eye Using Hollow Microneedles
Jiang, J., Moore, J. S., Edelhauser, H. F., & Prausnitz, M. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9756-3 · Cited by 208
Acyclovir-containing liposomes for potential ocular delivery
Law, S. L., Huang, K. J., & Chiang, C. H. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00192-3 · Cited by 202
Ideta, R., Tasaka, F., Jang, W.-D., Nishiyama, N., Zhang, G.-D., Harada, A., Yanagi, Y., Tamaki, Y., Aida, T., & Kataoka, K. (2005) · Nano Letters · doi:10.1021/nl051679d · Cited by 196
Nagarwal, R. C., Kumar, R., & Pandit, J. K. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.08.008 · Cited by 195
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery
Cholkar, K., Patel, A., Dutt Vadlapudi, A., & K. Mitra, A. (2012) · Recent Patents on Nanomedicinee · doi:10.2174/1877912311202020082 · Cited by 193
Self-citationNovel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189
ABRISHAMI, M., GANAVATI, S. Z., SOROUSH, D., ROUHBAKHSH, M., JAAFARI, M. R., & MALAEKEH-NIKOUEI, B. (2009) · Retina · doi:10.1097/iae.0b013e3181a2f42a · Cited by 184
Ocular Drug Delivery: Pharmacokinetic Considerations
Schoenwald, R. D. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018040-00001 · Cited by 183
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174 · cited 1×
“Therefore, the anionic HSA-NP could be promising drug delivery carrier for the treatment of AMD which required drug distribution to the choroid region in order to inhibit choroidal neovascularization[67].”
BackgroundTransport Barriers in Transscleral Drug Delivery for Retinal Diseases
Kim, S. H., Lutz, R. J., Wang, N. S., & Robinson, M. R. (2007) · Ophthalmic Research · doi:10.1159/000108117 · Cited by 172
Designing dendrimers for ocular drug delivery
Spataro, G., Malecaze, F., Turrin, C.-O., Soler, V., Duhayon, C., Elena, P.-P., Majoral, J.-P., & Caminade, A.-M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.10.017 · Cited by 172
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
Agnihotri, S. M., & Vavia, P. R. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.003 · Cited by 164
Dispersion of DMPC Liposomes in Contact Lenses for Ophthalmic Drug Delivery
Gulsen, D., Li, C.-C., & Chauhan, A. (2005) · Current Eye Research · doi:10.1080/02713680500346633 · Cited by 159
Sustained in vivo release from imprinted therapeutic contact lenses
Tieppo, A., White, C. J., Paine, A. C., Voyles, M. L., McBride, M. K., & Byrne, M. E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.087 · Cited by 158
Jaffe, G. J., McCallum, R. M., Branchaud, B., Skalak, C., Butuner, Z., & Ashton, P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.013 · Cited by 158
Kinoshita, S., Awamura, S., Oshiden, K., Nakamichi, N., Suzuki, H., & Yokoi, N. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.06.052 · Cited by 154
Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes
Abdelbary, G. A. (2009) · Pharmaceutical Development and Technology · doi:10.3109/10837450903479988 · Cited by 153
Thermosensitive Self-Assembling Block Copolymers as Drug Delivery Systems
Bonacucina, G., Cespi, M., Mencarelli, G., Giorgioni, G., & Palmieri, G. F. (2011) · Polymers · doi:10.3390/polym3020779 · Cited by 146
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 142
Pignatello, R., Ricupero, N., Bucolo, C., Maugeri, F., Maltese, A., & Puglisi, G. (2006) · AAPS PharmSciTech · doi:10.1208/pt070127 · Cited by 131
Zhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 131
PLGA–PEG–PLGA hydrogel for ocular drug delivery of dexamethasone acetate
Gao, Y., Sun, Y., Ren, F., & Gao, S. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003680826 · Cited by 130
Saettone, M. F., Chetoni, P., Cerbai, R., Mazzanti, G., & Braghiroli, L. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04663-7 · Cited by 129
Liaw, J., Chang, S.-F., & Hsiao, F.-C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301485 · Cited by 127
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Ibrahim, H. K., El-Leithy, I. S., & Makky, A. A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900279c · Cited by 124
Polyhydroxyethylaspartamide-based micelles for ocular drug delivery
Civiale, C., Licciardi, M., Cavallaro, G., Giammona, G., & Mazzone, M. G. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.028 · Cited by 120
Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels
KIM, J., & Chauhan, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.049 · Cited by 120
Derwent, J. J. K., & Mieler, W. F. (2008) · PubMed · Cited by 111
Molecularly imprinted therapeutic contact lenses
White, C. J., & Byrne, M. E. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003770098 · Cited by 102
Natarajan, J. V., Chattopadhyay, S., Ang, M., Darwitan, A., Foo, S. E. M., Zhen, M., Koo, M., Wong, T. T. L., & Venkatraman, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024513 · Cited by 100
Zhang, R., He, R., Jiang, Q., Guo, J., Xue, K., & Yuan, Y.-F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4373 · Cited by 98
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits
Musumeci, T., Bucolo, C., Carbone, C., Pignatello, R., Drago, F., & Puglisi, G. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.014 · Cited by 97
Burgalassi, S., Chetoni, P., Monti, D., et al. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00261-2 · Cited by 96
Zhang, L., Li, Y., Zhang, C., Wang, Y., & 宋存先 (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6428 · Cited by 94
Liposomes as an ocular delivery system of fluconazole: in‐vitro studies
HABIB, F. S., Fouad, E. A., Abdel‐Rhaman, M. S., & Fathalla, D. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01584.x · Cited by 92
Bu, H., Gukasyan, H. J., Goulet, L., Lou, X., Xiang, C. D., & Koudriakova, T. B. (2007) · Current Drug Metabolism · doi:10.2174/138920007779815977 · Cited by 91
Inokuchi, Y., Hironaka, K., Fujisawa, T., Tozuka, Y., Tsuruma, K., Shimazawa, M., Takeuchi, H., & Hara, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4697 · Cited by 90
Fujisawa, T., Miyai, H., Hironaka, K., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.024 · Cited by 89
Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes
Sasaki, H., Karasawa, K., Hironaka, K., Tahara, K., Tozuka, Y., & Takeuchi, H. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.014 · Cited by 85
Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Abdelkader, H., & Alany, R. G. (2012) · Current Drug Delivery · doi:10.2174/156720112801323125 · Cited by 84
Tirucherai, G., & Mitra, A. K. (2003) · AAPS PharmSciTech · doi:10.1208/pt040345 · Cited by 81
Lajavardi, L., Bochot, A., Camelo, S., Thillaye-Goldenberg, B., Naud, M., Béhar‐Cohen, F., Fattal, E., & de Kozak, Y. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1305 · Cited by 81
Eye drop delivery of nano‐polymeric micelle formulated genes with cornea‐specific promoters
Tong, Y.-C., Chang, S., Liu, C., Kao, W. W. ‐., Huang, C. H., & Liaw, J. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1093 · Cited by 71
Intravitreal Pharmacokinetics of Plain and Liposome-Entrapped Fluconazole in Rabbit Eyes
Gupta, S. K., Velpandian, T., Dhingra, N., & Jaiswal, J. K. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.511 · Cited by 64
Edaravone-Loaded Liposome Eyedrops Protect against Light-Induced Retinal Damage in Mice
Shimazaki, H., Hironaka, K., Fujisawa, T., Tsuruma, K., Tozuka, Y., Shimazawa, M., Takeuchi, H., & Hara, H. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7983 · Cited by 62
Novel approaches for retinal drug delivery
Kurz, D. E., & Ciulla, T. A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(02)00034-2 · Cited by 61
Liang, H., Brignole‐Baudouin, F., Rabinovich‐Guilatt, L., Mao, Z., Riancho, L., Faure, M.-O., Warnet, J., Lambert, G., & Baudouin, C. (2008) · PubMed Central · Cited by 58
Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation
Keam, S. J., Scott, L. J., & Curran, M. P. (2003) · Drugs · doi:10.2165/00003495-200363220-00016 · Cited by 56
Effects of Three Penetration Enhancers on Transcorneal Permeation of Cyclosporine
van der Bijl, P., Eyk, A. D. V., & Meyer, D. (2001) · Cornea · doi:10.1097/00003226-200107000-00013 · Cited by 54
Ocular Distribution of Difluprednate Ophthalmic Emulsion 0.05% in Rabbits
Tajika, T., Isowaki, A., & Sakaki, H. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0093 · Cited by 53
Ideta, R., Yanagi, Y., Tamaki, Y., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01315-2 · Cited by 53
Gunda, S., Hariharan, S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.465 · Cited by 52
Evaluation of Clearance Mechanisms with Transscleral Drug Delivery
Lee, S. J., He, W., Robinson, S. B., Robinson, M. R., Csaky, K. G., & Kim, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5337 · Cited by 49
Tirucherai, G., Dias, C. S., & Mitra, A. K. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021081 · Cited by 47
Hornof, M., & Bernkop‐Schnürch, A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10258 · Cited by 46
Transcorneal Iontophoresis for Delivery of Ciprofloxacin Hydrochloride
Vaka, S. R. K., Sammeta, S. M., Day, L. B., & Murthy, S. N. (2008) · Current Eye Research · doi:10.1080/02713680802270945 · Cited by 46
Sustained Subconjunctival Protein Delivery Using a Thermosetting Gel Delivery System
Rieke, E. R., Amaral, J., Becerra, S. P., & Lutz, R. J. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0059 · Cited by 45
Scoper, S. V., Kabat, A. G., Owen, G. R., et al. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0019-9 · Cited by 40
Liposome-bound cyclosporine: Clearance after intravitreal injection
Alghadyan, A. A., Peyman, G. A., Khoobehi, B., Milner, S., & Liu, K.-R. (1988) · International Ophthalmology · doi:10.1007/bf00137135 · Cited by 33
Zhang, J., Guan, P., Wang, T., Chang, D., Jiang, T., & Wang, S. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.09.0006 · Cited by 27
Karasawa, F., Ehata, T., Okuda, T., & Satoh, T. (2000) · Journal of Anesthesia · doi:10.1007/s005400070020 · Cited by 23
Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate
Singh, K., & Shinde, U. A. (2010) · Current Drug Delivery · doi:10.2174/156720110791561008 · Cited by 23
The intraocular dynamics of vancomycin hydrochloride ophthalmic ointment (TN-011) in rabbits
Fukuda, M., Hanazome, I., & Sasaki, K. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0219-1 · Cited by 14
Some studies on the preservation of indometacin suspensions intended for ophthalmic use.
Vulovic, N., Primorac, M., Stupar, M., et al. (1990) · PubMed · Cited by 8
Cited by
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
Su, Y., Zhang, B., Sun, R., Liu, W., Zhu, Q., Zhang, X., Wang, R., & Chen, C. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1938756 · Cited by 617
A swarm of slippery micropropellers penetrates the vitreous body of the eye
Wu, Z., Troll, J., Jeong, H.-H., Wei, Q., Stang, M., Ziemssen, F., Wang, Z., Dong, M., Schnichels, S., Qiu, T., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat4388 · Cited by 567
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
Metadata
- Authors
- Patel, A.
- Venue
- World Journal of Pharmacology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2013
- Volume
- 2
- Issue
- 2
- Pages
- 47
- ISSN
- 2220-3192 (ISSN-L)
- OpenAlex
- W2324350546
- Cited by
- 890
- References
- 95
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.